Bright Path, a U.S.-based advanced pharmaceutical manufacturer, today applauded the President's Fiscal Year 2027 budget proposal for its significant investments in advanced manufacturing technologies ...

The main market opportunities include upskilling professionals in pharmaceutical and biotech manufacturing, meeting growing demand for aseptic processing expertise, and offering RAPS-recognized ...

F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...

The threat of new tariffs on drugmakers has set off a debate within the biotech industry over whether to cut voluntary pricing deals with the Trump administration in exchange for exemptions. Why it ...

Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary — The global cell therapy manufacturing market is hitting a pivotal inflection point.

For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.

In this clip from episode 1 of Manufacturing Intelligence, Richard Jaenisch of Open Biopharma discusses step 1 in adopting AI ...

As sustainability becomes a core focus for biotech, there is a growing need for professionals who can implement eco-friendly practices in biomanufacturing while ensuring regulatory compliance. This ...

DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...

DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...

VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis Therapeutics (“DTx”), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic ...

EVERETT — Sana Biotechnology has canceled plans to build a major biotech manufacturing factory in Bothell that was supposed to employ hundreds of workers within a few years. The publicly traded ...